Items tagged with Vaccines
WGNV newsletter: Latest updates on TB vaccines (post)
The Stop TB Partnership Working Group on New TB Vaccines (WGNV) released a newsletter with the latest updates related to the TB vaccine research and development.
UCT prof calls for increased investment in TB vaccine research (post)
During a panel discussion of the United Nations High-level Meeting on TB held in New York City on 22 September 2023, Professor Mark Hatherill, the director at the South African Tuberculosis Vaccine Initiative (SATVI) based at the University of Cape Town (UCT), called for a quantum jump in TB vaccine research and development (R&D) funding, to deliver the transformative tools needed to end the TB pandemic.
WHO call for expression of interest: Civil society representatives in the TB vaccine accelerator council (post)
The World Health Organization (WHO) Global TB Program is providing secretariat support to the TB vaccine accelerator council, which was recently established to facilitate the development, licensing and use of safe TB vaccines that are impactful in halting the TB epidemic. Civil society representatives with relevant expertise and experience are invited to respond to a call for expression of interest to be engaged in the leadership group of the Council. The deadline to apply is 18 October 2023.
TB vaccine discovery paves path to end no. 1 killer of people living with HIV (post)
Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among people worldwide living with HIV.
Promising breakthroughs ignite hope for a novel and effective TB vaccine (post)
A recent Npj Vaccines study discussed the success and challenges of developing different tuberculosis (TB) vaccine types.
TB Vax ARM: What's next for TB R&D post-HLM? A pre-Union virtual meeting (post)
In preparation for the Union World Conference on Lung Health in Paris, France on 15-18 November 2023, the TB Vaccine Advocacy Roadmap (TB Vax ARM) will host a virtual meeting on 2 November 2023 exploring what’s next for TB research and development (R&D) following the United Nations High-Level Meeting on TB (HLM).
University of Montana leads $12.3M contract to advance TB vaccine (post)
MISSOULA, 23 October 2023 – The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.
Routine vaccines – Tuberculosis (post)
Efforts to fight the world’s biggest infectious killer are about to get a boost, with new vaccines on the horizon.
Longhorn Vaccines and Diagnostics presents targeted vaccine approach for Mycobacterium tuberculosis with LHNVD-301 (post)
Preclinical results indicate robust antibody activity against tuberculosis and antimicrobial resistant virus strains; Data presented at The Union World Conference on Lung Health 2023
To build better TB vaccines, Saint Louis University researchers develop a new model by leveraging an old vaccine (post)
Each year, tuberculosis (TB) kills more people than any other infectious disease, falling out of the top spot only temporarily during the COVID-19 pandemic.
Page 24 of 30 · Total posts: 0
←First 23 24 25 Last→